Engineering autoimmune disease models using organoids: Harnessing microenvironmental engineering for precision medicine and immunological recapitulation

Bioengineering & Translational Medicine · Published 2026-07-30 · DOI 10.1002/btm2.70162

Free full text

Authors (5)

Chang‐Jin Lee, Yeojin Kim, Misu Kim, Yeri Alice Rim, Ji Hyeon Ju

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lee, C., Kim, Y., Kim, M., et al. (2026). Engineering autoimmune disease models using organoids: Harnessing microenvironmental engineering for precision medicine and immunological recapitulation. Bioengineering & Translational Medicine. https://doi.org/10.1002/btm2.70162

Related articles

• Strategies to overcome the limitations of current organoid technology - engineered organoids · Journal of Tissue Engineering · 2025 · Cites or is cited by this article
• Stealth polymer coatings of reactive oxygen species scavenging nanoparticles for immune response mitigation · Bioengineering & Translational Medicine · 2026 · Same journal
• Stability of bacteriophages in spray‐dried polymeric formulations: Effect of excipient polyvinylpyrrolidone glass transition temperature and molecular weight · Bioengineering & Translational Medicine · 2026 · Same journal
• Evaluation of a functionalized chitosan and alginate multilayer conformal nanocoating toward improving islet survival in syngeneic mouse islet transplantation · Bioengineering & Translational Medicine · 2026 · Same journal
• PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo · Bioengineering & Translational Medicine · 2026 · Same journal
• Exogenous matrix‐free biomanufacturing of glioblastoma organoids enables autonomous assembly of neurovascular‐like structures and extracellular matrix · Bioengineering & Translational Medicine · 2026 · Same journal
• Mechanical fingerprints in breast cancer research: A multimodal experimental approach · Bioengineering & Translational Medicine · 2026 · Same journal
• Human induced pluripotent stem cell‐derived mesenchymal stromal cells regenerate diabetic ischemic muscle · Bioengineering & Translational Medicine · 2026 · Same journal
• Dynamic pillar–perfusion platform for screening enzyme‐induced self‐assembling peptide therapeutics in 3D breast cancer spheroids · Bioengineering & Translational Medicine · 2026 · Same journal
• Chimeric antigen receptor‐macrophages: A new paradigm for cell therapy · Bioengineering & Translational Medicine · 2026 · Same journal